BioMEMS Diagnostics, Inc.

COMMERCE, MI · Founded 2022 · CIK 0001962502 · Medtech · Private

Non-invasive point-of-care diagnostic platform with microfluidic test cartridges and handheld analyzers for biomarker detection

biomemsdiagnostics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$3.0M
1 Form D · Jan 2023
45 months since last filing
Contracts
—
No federal contracts on record
Patents
7
0 granted · 7 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$3,000,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1558MASSTECH, INC.——
1559Pulsario Enterprise Holdings, Inc—$20M
1560Paerosol LLC—$250K
1561BioMEMS Diagnostics, Inc.—$3.0M
1562FluxWear, Inc.—$1.0M
1563AP LIFESCIENCES, LLC——
1564MEDITRACE LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 6 related persons
  • Zaine BairdExecutive Officer
  • John BohanExecutive Officer
  • Andrew DahlDirector · Executive Officer · Promoter
  • Casey FowlerDirector · Executive Officer · Promoter
  • Jay OffenDirector · Executive Officer
  • Michael PugiaExecutive Officer

Patents

USPTO · 0 granted of 7
  • Automatic Diagnostic Tracingapplication
  • System and Method for Multiplexed Dry Agent Additionapplication
  • Microwell Microelectrode Filtration Sensorapplication
  • Cellular Response Analysis Methodapplication
  • Method for Correction for Sample Volumeapplication
  • Oxidative Mass Labelingapplication
  • Method for Sample Collection and Meteringapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.